🇺🇸 Glargine in United States

11,671 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 1,826 reports (15.65%)
  2. Hypoglycaemia — 1,698 reports (14.55%)
  3. Device Mechanical Issue — 1,184 reports (10.14%)
  4. Nausea — 1,052 reports (9.01%)
  5. Dyspnoea — 1,048 reports (8.98%)
  6. Acute Kidney Injury — 1,026 reports (8.79%)
  7. Drug Ineffective — 993 reports (8.51%)
  8. Diarrhoea — 974 reports (8.35%)
  9. Hyperglycaemia — 967 reports (8.29%)
  10. Vomiting — 903 reports (7.74%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Glargine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glargine in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.